129 related articles for article (PubMed ID: 15214046)
1. Gene expression profile of B cells from Xid mice and Btk knockout mice.
Lindvall JM; Blomberg KE; Berglöf A; Yang Q; Smith CI; Islam TC
Eur J Immunol; 2004 Jul; 34(7):1981-91. PubMed ID: 15214046
[TBL] [Abstract][Full Text] [Related]
2. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.
Lindvall JM; Blomberg KE; Väliaho J; Vargas L; Heinonen JE; Berglöf A; Mohamed AJ; Nore BF; Vihinen M; Smith CI
Immunol Rev; 2005 Feb; 203():200-15. PubMed ID: 15661031
[TBL] [Abstract][Full Text] [Related]
3. Tracking the response of Xid B cells in vivo: TI-2 antigen induces migration and proliferation but Btk is essential for terminal differentiation.
Vinuesa CG; Sunners Y; Pongracz J; Ball J; Toellner KM; Taylor D; MacLennan IC; Cook MC
Eur J Immunol; 2001 May; 31(5):1340-50. PubMed ID: 11465091
[TBL] [Abstract][Full Text] [Related]
4. Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase.
Dingjan GM; Maas A; Nawijn MC; Smit L; Voerman JS; Grosveld F; Hendriks RW
EMBO J; 1998 Sep; 17(18):5309-20. PubMed ID: 9736610
[TBL] [Abstract][Full Text] [Related]
5. Distinct gene expression signature in Btk-defective T1 B-cells.
Lindvall JM; Blomberg KE; Berglöf A; Smith CI
Biochem Biophys Res Commun; 2006 Jul; 346(2):461-9. PubMed ID: 16764821
[TBL] [Abstract][Full Text] [Related]
6. The X-linked immunodeficiency defect in the mouse is corrected by expression of human Bruton's tyrosine kinase from a yeast artificial chromosome transgene.
Maas A; Dingjan GM; Savelkoul HF; Kinnon C; Grosveld F; Hendriks RW
Eur J Immunol; 1997 Sep; 27(9):2180-7. PubMed ID: 9341757
[TBL] [Abstract][Full Text] [Related]
7. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.
Glassford J; Soeiro I; Skarell SM; Banerji L; Holman M; Klaus GG; Kadowaki T; Koyasu S; Lam EW
Oncogene; 2003 Apr; 22(15):2248-59. PubMed ID: 12700661
[TBL] [Abstract][Full Text] [Related]
8. Regulation of B cell survival in xid mice by the proto-oncogene bcl-2.
Woodland RT; Schmidt MR; Korsmeyer SJ; Gravel KA
J Immunol; 1996 Mar; 156(6):2143-54. PubMed ID: 8690903
[TBL] [Abstract][Full Text] [Related]
9. B cells from CBA/N mice do not proliferate following ligation of CD40.
Hasbold J; Klaus GG
Eur J Immunol; 1994 Jan; 24(1):152-7. PubMed ID: 7517360
[TBL] [Abstract][Full Text] [Related]
10. xid affects events leading to B cell cycle entry.
Brorson K; Brunswick M; Ezhevsky S; Wei DG; Berg R; Scott D; Stein KE
J Immunol; 1997 Jul; 159(1):135-43. PubMed ID: 9200448
[TBL] [Abstract][Full Text] [Related]
11. Early arrest in B cell development in transgenic mice that express the E41K Bruton's tyrosine kinase mutant under the control of the CD19 promoter region.
Maas A; Dingjan GM; Grosveld F; Hendriks RW
J Immunol; 1999 Jun; 162(11):6526-33. PubMed ID: 10352268
[TBL] [Abstract][Full Text] [Related]
12. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages.
de Weers M; Verschuren MC; Kraakman ME; Mensink RG; Schuurman RK; van Dongen JJ; Hendriks RW
Eur J Immunol; 1993 Dec; 23(12):3109-14. PubMed ID: 8258324
[TBL] [Abstract][Full Text] [Related]
13. Accelerated emigration of B lymphocytes in the Xid mouse.
Cariappa A; Kim TJ; Pillai S
J Immunol; 1999 Apr; 162(8):4417-23. PubMed ID: 10201977
[TBL] [Abstract][Full Text] [Related]
14. A re-evaluation of the effects of X-linked immunodeficiency (xid) mutation on B cell differentiation and function in the mouse.
Klaus GG; Holman M; Johnson-Léger C; Elgueta-Karstegl C; Atkins C
Eur J Immunol; 1997 Nov; 27(11):2749-56. PubMed ID: 9394795
[TBL] [Abstract][Full Text] [Related]
15. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells.
Smith CI; Baskin B; Humire-Greiff P; Zhou JN; Olsson PG; Maniar HS; Kjellén P; Lambris JD; Christensson B; Hammarström L
J Immunol; 1994 Jan; 152(2):557-65. PubMed ID: 8283037
[TBL] [Abstract][Full Text] [Related]
16. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice.
Rawlings DJ; Saffran DC; Tsukada S; Largaespada DA; Grimaldi JC; Cohen L; Mohr RN; Bazan JF; Howard M; Copeland NG
Science; 1993 Jul; 261(5119):358-61. PubMed ID: 8332901
[TBL] [Abstract][Full Text] [Related]
17. Cell specific expression of human Bruton's agammaglobulinemia tyrosine kinase gene (Btk) is regulated by Sp1- and Spi-1/PU.1-family members.
Müller S; Sideras P; Smith CI; Xanthopoulos KG
Oncogene; 1996 Nov; 13(9):1955-64. PubMed ID: 8934542
[TBL] [Abstract][Full Text] [Related]
18. Lysine acetylation regulates Bruton's tyrosine kinase in B cell activation.
Liu Z; Mai A; Sun J
J Immunol; 2010 Jan; 184(1):244-54. PubMed ID: 19949111
[TBL] [Abstract][Full Text] [Related]
19. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.
Thomas JD; Sideras P; Smith CI; Vorechovský I; Chapman V; Paul WE
Science; 1993 Jul; 261(5119):355-8. PubMed ID: 8332900
[TBL] [Abstract][Full Text] [Related]
20. CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction.
Santos-Argumedo L; Lund FE; Heath AW; Solvason N; Wu WW; Grimaldi JC; Parkhouse RM; Howard M
Int Immunol; 1995 Feb; 7(2):163-70. PubMed ID: 7734414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
